These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23612201)

  • 1. High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.
    Woodrow CJ; Dahlström S; Cooksey R; Flegg JA; Le Nagard H; Mentré F; Murillo C; Ménard D; Nosten F; Sriprawat K; Musset L; Quashie NB; Lim P; Fairhurst RM; Nsobya SL; Sinou V; Noedl H; Pradines B; Johnson JD; Guerin PJ; Sibley CH; Le Bras J
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3121-30. PubMed ID: 23612201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen.
    Al-Shamahy H; Al-Harazy AH; Harmal NS; Al-Kabsi AM
    Ann Saudi Med; 2007; 27(6):432-6. PubMed ID: 18059124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
    Cheruiyot AC; Auschwitz JM; Lee PJ; Yeda RA; Okello CO; Leed SE; Talwar M; Murthy T; Gaona HW; Hickman MR; Akala HM; Kamau E; Johnson JD
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2417-24. PubMed ID: 26856829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo-in vitro model for the assessment of clinically relevant antimalarial cross-resistance.
    Noedl H; Wernsdorfer WH; Krudsood S; Wilairatana P; Viriyavejakul P; Kollaritsch H; Wiedermann G; Looareesuwan S
    Am J Trop Med Hyg; 2001 Dec; 65(6):696-9. PubMed ID: 11791959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.
    Fukuda N; Tachibana SI; Ikeda M; Sakurai-Yatsushiro M; Balikagala B; Katuro OT; Yamauchi M; Emoto S; Hashimoto M; Yatsushiro S; Sekihara M; Mori T; Hirai M; Opio W; Obwoya PS; Auma MA; Anywar DA; Kataoka M; Palacpac NMQ; Odongo-Aginya EI; Kimura E; Ogwang M; Horii T; Mita T
    Parasitol Int; 2021 Apr; 81():102277. PubMed ID: 33370608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.
    Noedl H; Krudsood S; Leowattana W; Tangpukdee N; Thanachartwet W; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Yingyuen K; Sriwichai S; Ohrt C; Knirsch C
    Antimicrob Agents Chemother; 2007 Feb; 51(2):651-6. PubMed ID: 17116669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
    Fernández D; Segura C; Arboleda M; Garavito G; Blair S; Pabón A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6354-9. PubMed ID: 25114141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, quinine, mefloquine and halofantrine in Abidjan (Côte d'Ivoire).
    Yavo W; Bla KB; Djaman AJ; Assi SB; Basco LK; Mazabraud A; Koné M
    Afr Health Sci; 2010 Jun; 10(2):111-6. PubMed ID: 21326960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
    Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
    Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
    Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
    Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B
    Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
    Chaijaroenkul W; Bangchang KN; Mungthin M; Ward SA
    Malar J; 2005 Aug; 4():37. PubMed ID: 16060967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
    Benito A; Roche J; Molina R; Amela C; Alvar J
    Am J Trop Med Hyg; 1995 Nov; 53(5):526-31. PubMed ID: 7485712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant malaria in Bangladesh: an in vitro assessment.
    Noedl H; Faiz MA; Yunus EB; Rahman MR; Hossain MA; Samad R; Miller RS; Pang LW; Wongsrichanalai C
    Am J Trop Med Hyg; 2003 Feb; 68(2):140-2. PubMed ID: 12641401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.